[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 564008, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 220590, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 386032, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 564088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.05, "open": 1.04, "dayLow": 1.04, "dayHigh": 1.07, "regularMarketPreviousClose": 1.05, "regularMarketOpen": 1.04, "regularMarketDayLow": 1.04, "regularMarketDayHigh": 1.07, "payoutRatio": 0.0, "beta": 0.619, "forwardPE": -3.451613, "volume": 783886, "regularMarketVolume": 783886, "averageVolume": 868267, "averageVolume10days": 906910, "averageDailyVolume10Day": 906910, "bid": 0.7488, "ask": 1.35, "bidSize": 2, "askSize": 2, "marketCap": 89590512, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 2.24, "allTimeHigh": 10.0, "allTimeLow": 0.45, "fiftyDayAverage": 1.15872, "twoHundredDayAverage": 1.204965, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 71538008, "profitMargins": 0.0, "floatShares": 80582895, "sharesOutstanding": 83729448, "sharesShort": 2192624, "sharesShortPriorMonth": 1867823, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.026199998, "heldPercentInsiders": 0.04182, "heldPercentInstitutions": 0.083129995, "shortRatio": 2.38, "shortPercentOfFloat": 0.0272, "impliedSharesOutstanding": 84293410, "bookValue": 0.143, "priceToBook": 7.4825177, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -37548816, "trailingEps": -0.34, "forwardEps": -0.31, "enterpriseToEbitda": -1.781, "52WeekChange": -0.43386245, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 1.07, "targetHighPrice": 8.907371, "targetLowPrice": 5.917694, "targetMeanPrice": 7.781403, "targetMedianPrice": 8.150272, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 18195052, "totalCashPerShare": 0.217, "ebitda": -40178008, "totalDebt": 142554, "quickRatio": 2.303, "currentRatio": 2.465, "debtToEquity": 1.207, "returnOnAssets": -1.08743, "returnOnEquity": -2.76409, "freeCashflow": -12288195, "operatingCashflow": -25066712, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1759535632, "regularMarketTime": 1759521601, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -0.00934734, "postMarketPrice": 1.0699, "postMarketChange": -0.000100017, "regularMarketChange": 0.0200001, "regularMarketDayRange": "1.04 - 1.07", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 868267, "fiftyTwoWeekLowChange": 0.29900002, "fiftyTwoWeekLowChangePercent": 0.38780805, "fiftyTwoWeekRange": "0.771 - 2.24", "fiftyTwoWeekHighChange": -1.17, "fiftyTwoWeekHighChangePercent": -0.5223214, "fiftyTwoWeekChangePercent": -43.386246, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.31, "epsCurrentYear": -0.415, "priceEpsCurrentYear": -2.5783134, "fiftyDayAverageChange": -0.088719964, "fiftyDayAverageChangePercent": -0.07656722, "twoHundredDayAverageChange": -0.13496494, "twoHundredDayAverageChangePercent": -0.11200736, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": 1.90477, "regularMarketPrice": 1.07, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]